[1] Lü Y, Liu B, Liu Y, et al. TGF-β1 combined with Sal-B promotes cardiomyocyte differentiation of rat mesenchymal stem cells[J]. Exp Ther Med, 2018, 15(6): 5359-5364.
[2] Shen X, Pan B, Zhou H, et al. Differentiation of mesenchymal stem cells into cardiomyocytes is regulated by miRNA-1-2 via WNT signaling pathway[J]. J Biomed Sci, 2017, 24(1): 29.
[3] Chen Y, Wang C, Huang Q, et al. Caveolin-1 plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells into cardiomyocytes[J]. Cardiology, 2017, 136(1): 40-48.
[4] Lü Y, Liu B, Wang HP, et al. Transforming growth factor-β1 combined with tanshinoneⅡA induces bone marrow mesenchymal stem cells differentiating into cardiomyocyte-like cells in vitro[J]. Acta Anatomica Sinica, 2016, 47(5): 620-627. (in Chinese)
吕洋, 刘博, 王海萍, 等. 转化生长因子β1和丹参酮ⅡA联合诱导骨髓间充质干细胞向心肌样细胞的分化[J]. 解剖学报, 2016, 47(5): 620-627.
[5] Hlaing SM, Garcia LA, Contreras JR, et al.1,25-vitamin D3 promotes cardiac differentiation through modulation of theWnt signaling pathway[J]. J Mol Endocrinol, 2014, 53(3):303-317.
[6] Richart T, Li Y, Staessen JA. Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension[J]. Am J Hypertens, 2007, 20(9):1007-1015.
[7] Zerwekh JE. Blood biomarkers of vitamin D status[J]. Am J Clin Nutr, 2008, 87(4):1087S-1091S.
[8] Prietl B, Treiber G, Pieber TR, et al.Vitamin D and immune function[J]. Nutrients, 2013, 5(7):2502-2521.
[9] Stivelman E, Retnakaran R. Role of vitamin D in the pathophysiology and treatment of type 2 diabetes[J]. Curr Diabetes Rev, 2012, 8(1):42-47.
[10]Gardner DG,Chen S,Glenn DJ. Vitamin D and the heart[J]. Am J Physiol Regul Integr Comp Physiol,2013, 305(9):R969-977.
[11]Nibbelink KA, Tishkoff DX, Hershey SD, et al.1,25(OH)2 vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte[J]. J Steroid Biochem Mol Biol, 2007, 103(3-5):533-537.
[12]O’Connell TD, Berry JE, Jarvis AK, et al.1,25-dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy[J]. Am J Physiol, 1997, 272(4 Pt 2):H1751-1758.
[13]Kim IM, Norris KC, Artaza JN. Vitamin D and cardiac differentiation[J]. Vitam Horm, 2016, 100:299-320.
[14]Lehrer SS, Geeves MA. The myosin-activated thin filament regulatory state, M–-open:a link to hypertrophic cardiomyopathy (HCM) [J]. J Muscle Res Cell Motil, 2014, 35(2):153-160.
[15]Gunning P, O’Neill G, Hardeman E. Tropomyosin-based regulation of the actin cytoskeleton in time and space[J]. Physiol Rev, 2008, 88(1):1-35.
[16]Ruscic KJ, Miceli F, Villalba-Galea CA, et al. IKs channels open slowly because KCNE1 accessory subunits slow the movement of S4 voltage sensors in KCNQ1 pore-forming subunits[J]. Proc Natl Acad Sci USA, 2013, 110(7):E559-566.
[17]Li N, Hou XL. Differentiation of human bone marrow mesenchymal stem cells into cardiomyocyte like cells[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(4):401-404. (in Chinese)
李宁,侯相麟. 人骨髓间充质干细胞分化为心肌样细胞的研究[J]. 中国临床药理学与治疗学,2007,12(4):401-404.
[18]Zhang J, Xiong J. Advances in clinical application of cardiac troponin[J]. Chinese Journal of Cardiovascular Rehabilitation Medicine, 2018, 27(3):360-364. (in Chinese)
张敬, 熊娟. 心肌肌钙蛋白的临床应用进展[J]. 心血管康复医学杂志, 2018, 27(3):360-364.
[19]Zhang X, Wang J, Wang B, et al.A novel missense mutation of GATA4 in a Chinese family with congenital heart disease[J]. PLoS One, 2016, 11(7):e0158904.
[20]Kasahara H, Bartunkova S, Schinke M, et al.Cardiac and extracardiac expression of Csx/Nkx2.5 homeodomain protein[J]. Circ Res, 1998, 82(9):936-946.
|